Multiple studies have shown that Leptin is related to tumor development and fatigue symptoms and can affect tumor progression and fatigue occurrence through the regulation of metabolism, immune, and neuroendocrine systems, among others [56–58]. This evidence concerns the gene LEP and neoplasm.